Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 132 participants.
Also called NCT02490904
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 132 participants
- Registry
-
NCT02490904
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02490904. Randomized; quadruple masking; primary purpose treatment. Start 2016-10-19 (actual); primary completion 2021-11-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
- Acronym
- EPURE
- Condition
- End-stage Renal Disease
- Intervention (Drug)
- Eplerenone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Central Hospital, Nancy, France
Record details
- Record id
cardio:ct-nct02490904- Content hash
8a202ba8f2dae8eb03c977a9c14318bc6d4dd2ab609d5ec2faa2b9ae9cc1b57b